Welcome to our dedicated page for ARTEMIS GOLD news (Ticker: ARGTF), a resource for investors and traders seeking the latest updates and insights on ARTEMIS GOLD stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect ARTEMIS GOLD's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of ARTEMIS GOLD's position in the market.
Beedie Investments has exercised warrants to acquire 11,111,111 common shares of Artemis Gold Inc. (ARGTF) at $1.08 per share. Prior to this transaction, Beedie and its joint actors owned 56,618,973 common shares, 11,111,111 warrants, 378,000 options, and 11,000 deferred stock units (DSUs) in Artemis Gold. After the warrant exercise, Beedie's holdings increased to 67,730,084 common shares, 378,000 options, and 11,000 DSUs. Assuming full exercise of remaining options and DSUs, Beedie would own approximately 31.54% of Artemis Gold's outstanding shares. The securities are held for investment purposes, with Beedie reserving the right to make future transactions based on market conditions.
FAQ
What is the current stock price of ARTEMIS GOLD (ARGTF)?
What is the market cap of ARTEMIS GOLD (ARGTF)?
